Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

Fortunato Ciardiello, Giampaolo Tortora · PubMed · 2001 · 988 citations

Medicine, Oncology, Pharmacology +17

Molecular cloning of syndecan, an integral membrane proteoglycan.

Scott Saunders, Markku Jalkanen, Susan O'Farrell et al. · The Journal of Cell Biology · 1989 · 503 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma

Harvey I. Pass, Stephen M. Levin, Michael Harbut et al. · New England Journal of Medicine · 2012 · 281 citations · Full text

Medicine, Cancer Biology, Pathology +16

Soluble Mesothelin–Related Peptides in the Diagnosis of Malignant Pleural Mesothelioma

Arnaud Scherpereel, Bogdan Grigoriu, Massimo Conti et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 233 citations

Medicine, Oncology, Pathology +15

Malignant Mesothelioma and Occupational Exposure to Asbestos: A Clinicopathological Correlation of 1445 Cases

Victor L. Roggli, Anupama Sharma, Kelly J. Butnor et al. · Ultrastructural Pathology · 2002 · 216 citations

Medicine, Oncology, Pathology +14